
Happiness Biotech Group Limited HAPP
Annual report 2022
added 08-16-2022
Happiness Biotech Group Limited P/CF Ratio 2011-2026 | HAPP
Annual P/CF Ratio Happiness Biotech Group Limited
| 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| - | - | 2.21 | 14.1 | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 14.1 | 2.21 | 8.13 |
P/CF Ratio of other stocks in the Biotechnology industry
| Issuer | P/CF Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
Acorda Therapeutics
ACOR
|
-1.2 | - | -24.86 % | $ 820 K | ||
|
Adverum Biotechnologies
ADVM
|
-0.826 | - | - | $ 86.2 M | ||
|
MorphoSys AG
MOR
|
-0.654 | - | 2.43 % | $ 254 M | ||
|
Akari Therapeutics, Plc
AKTX
|
-765 | $ 5.12 | 11.55 % | $ 345 B | ||
|
Alterity Therapeutics Limited
ATHE
|
-94.9 | $ 3.97 | 6.43 % | $ 9.55 B | ||
|
Akouos
AKUS
|
-2.7 | - | 0.23 % | $ 488 M | ||
|
Alnylam Pharmaceuticals
ALNY
|
77.9 | $ 320.13 | -3.98 % | $ 41.9 B | ||
|
Applied Molecular Transport
AMTI
|
-0.236 | - | - | $ 10.1 M | ||
|
I-Mab
IMAB
|
-0.266 | - | - | $ 866 M | ||
|
AlloVir
ALVR
|
-0.632 | - | 4.14 % | $ 49.1 M | ||
|
Burford Capital Limited
BUR
|
11.6 | $ 4.67 | -1.27 % | $ 766 M | ||
|
Alexion Pharmaceuticals, Inc.
ALXN
|
11.6 | - | - | $ 40.3 B | ||
|
Genfit SA
GNFT
|
1.68 K | - | 2.54 % | $ 160 B | ||
|
Biophytis SA
BPTS
|
-23.1 | - | -13.47 % | $ 169 M | ||
|
Aligos Therapeutics
ALGS
|
-0.799 | $ 7.66 | 3.23 % | $ 75.7 M | ||
|
Allakos
ALLK
|
-0.976 | - | - | $ 28.6 M | ||
|
Ayala Pharmaceuticals
AYLA
|
-0.224 | - | - | $ 7.46 M | ||
|
EyeGate Pharmaceuticals, Inc.
EYEG
|
-3.88 | - | -1.52 % | $ 24.7 M | ||
|
Midatech Pharma plc
MTP
|
-13.2 | - | -18.52 % | $ 27.3 M | ||
|
Applied Therapeutics
APLT
|
-9.8 | - | - | $ 8.42 M | ||
|
Aptinyx
APTX
|
-0.159 | - | -39.0 % | $ 4.57 M | ||
|
Aravive
ARAV
|
-0.928 | - | -13.39 % | $ 1.45 M | ||
|
Brainstorm Cell Therapeutics
BCLI
|
-0.696 | - | -2.5 % | $ 5.88 M | ||
|
Amphastar Pharmaceuticals
AMPH
|
8 | $ 21.81 | 0.6 % | $ 1.02 B | ||
|
CymaBay Therapeutics
CBAY
|
-47.3 | - | - | $ 3.45 B | ||
|
BioNTech SE
BNTX
|
70.7 | - | - | $ 27.2 B | ||
|
Институт стволовых клеток человека
ISKJ
|
-89 | - | - | - | ||
|
Cabaletta Bio
CABA
|
-2.16 | $ 3.52 | 3.53 % | $ 354 M | ||
|
Advaxis
ADXS
|
-0.0633 | - | -9.65 % | $ 45.9 M | ||
|
Aeterna Zentaris
AEZS
|
-4.82 | - | 5.93 % | $ 314 M | ||
|
Can-Fite BioPharma Ltd.
CANF
|
-0.537 | $ 3.08 | -2.84 % | $ 5.07 M | ||
|
AgeX Therapeutics
AGE
|
-0.0018 | - | -10.17 % | $ 12.2 K | ||
|
ContraFect Corporation
CFRX
|
-0.0235 | - | -5.16 % | $ 5.39 M | ||
|
Galectin Therapeutics
GALT
|
-7.47 | $ 2.26 | -11.72 % | $ 144 M | ||
|
Aeglea BioTherapeutics
AGLE
|
-4.6 | - | - | $ 1.01 B | ||
|
Akebia Therapeutics
AKBA
|
4.92 | $ 1.35 | -12.9 % | $ 347 M | ||
|
Applied Genetic Technologies Corporation
AGTC
|
-0.64 | - | - | $ 26.5 M | ||
|
Aquestive Therapeutics
AQST
|
-8.91 | $ 4.26 | 0.47 % | $ 456 M | ||
|
Grifols, S.A.
GRFS
|
14.1 | $ 8.6 | -1.04 % | $ 6.83 B | ||
|
Arcutis Biotherapeutics
ARQT
|
-612 | $ 24.19 | -1.59 % | $ 3.08 B | ||
|
AIkido Pharma
AIKI
|
-1.17 | - | 1.93 % | $ 17.4 M | ||
|
BioDelivery Sciences International
BDSI
|
7.5 | - | -4.8 % | $ 255 M | ||
|
Autolus Therapeutics plc
AUTL
|
-1.14 | $ 1.61 | 8.05 % | $ 428 M | ||
|
Aptose Biosciences
APTO
|
-0.0645 | - | -45.71 % | $ 1.2 M | ||
|
BeiGene, Ltd.
BGNE
|
-1.8 K | - | 0.49 % | $ 251 B | ||
|
Checkpoint Therapeutics
CKPT
|
-5.15 | - | - | $ 169 M | ||
|
Caladrius Biosciences
CLBS
|
-0.185 | - | -16.75 % | $ 25.8 M | ||
|
AVROBIO
AVRO
|
-0.891 | - | 1083.1 % | $ 745 M | ||
|
Clearside Biomedical
CLSD
|
-5.59 | - | - | $ 25.3 M | ||
|
Celldex Therapeutics
CLDX
|
-9.67 | $ 33.86 | -0.03 % | $ 2.25 B |